Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 01:02:43 - browse：86

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Doctor of U.S. President Joe Biden says he is fit for duty

focus

WSS

How Medicaid coverage policies for immigrants impact new moms

Cholera vaccine supplies dangerously low, outbreaks surging

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Using force crossed my mind when examining a defiant young patient

Childhood vaccination ad campaign launches in the U.K.

Sanders adds drug shortage policies to pandemic preparedness bill

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

After affirmative action ruling, medical educators look to 'holistic review'

Childhood vaccination ad campaign launches in the U.K.

Tori Bowie and the unacceptable rates of Black maternal death

Elisabeth Bik tackles the widespread issue of research misconduct

After affirmative action ruling, medical educators look to 'holistic review'

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

How to save PrEP access — and even expand it

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

As demand for Covid shots wanes, Moderna seeks its next success

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

entertainment

Doctors find melanoma drugs effective against rare brain cancer

At Orexo, a ‘turning point’ for everything but digital health

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Cholera vaccine supplies dangerously low, outbreaks surging

Doctor of U.S. President Joe Biden says he is fit for duty

Cholera vaccine supplies dangerously low, outbreaks surging

knowledge

leisure time

focus

explore